Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2030

Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2030

Intravenous Solution Trends and Forecast

The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Intravenous Solution by Segment

The study includes a forecast for the global intravenous solution by product, nutrients, and region.

Intravenous Solution Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

Intravenous Solution Market by Nutrients [Shipment Analysis by Value from 2018 to 2030]:

• Carbohydrates
• Vitamins & Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others

Intravenous Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Intravenous Solution Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous solution companies profiled in this report include-

• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi

Intravenous Solution Market Insights

Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Features of the Global Intravenous Solution Market

Market Size Estimates: Intravenous solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intravenous solution market size by product, nutrients, and region in terms of value ($B).

Regional Analysis: Intravenous solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, nutrients, and regions for the intravenous solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous solution market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the intravenous solution market size?

Answer: The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030.

Q2. What is the growth forecast for intravenous solution market?

Answer: The global intravenous solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the intravenous solution market?

Answer: The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

Q4. What are the major segments for intravenous solution market?

Answer: The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets.

Q5. Who are the key intravenous solution market companies?

Answer: Some of the key intravenous solution companies are as follows:

• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi

Q6. Which intravenous solution market segment will be the largest in future?

Answer: Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Q7. In intravenous solution market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the intravenous solution market by product (total parenteral nutrition and peripheral parenteral nutrition), nutrients (carbohydrates, vitamins & minerals, single dose amino acids, parenteral lipid emulsion, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.